Aldesleukin Unknown Status Phase 1 / 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002616Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer